Prevalence, Strains, and Drug Susceptibility of Nontuberculous Mycobacteria Isolates from Tuberculous Suspects
Open Access
- 11 September 2021
- journal article
- research article
- Published by Briefland in Jundishapur Journal of Microbiology
- Vol. 14 (7)
- https://doi.org/10.5812/jjm.116750
Abstract
Background: The prevalence of nontuberculous mycobacteria (NTM) infection has been increasing globally. Many cases of NTM infection are misdiagnosed as Mycobacterium tuberculous (MTB) because of similar clinicoradiological features. Objectives: To determine the burden and characteristics of NTM infection, this study was done to evaluate clinical isolates collected from tuberculous (TB) suspects in a population from Northwest China. Methods: From January to December 2020, the clinical samples of 9,142 TB suspects were collected for the PCR-fluorescent probe and mycobacterial culture. The PCR-fluorescent probe-positive nucleic acid samples were further subjected to a DNA microarray for confirmation and species identification. Drug susceptibility testing (DST) was also carried out using the micropore plate method (MicroDSTTM) on isolates from NTM patients. Results: Of 9,412 TB suspects, 85 cases (0.9%) were clinically diagnosed with NTM infection according to the American Thoracic Society (ATS) guidelines. For the laboratory samples, a total of 169 NTM strains, identified by molecular biology methods, were classified into 10 species. The most common species were Mycobacterium chelonae/ Mycobacterium abscessus (64/169, 37.7%) and M. intracellulare (40/169, 23.7%). All strains showed the highest resistance to imipenem/cilastatin (85/85, 100%) and the highest susceptibility to linezolid (4/85, 4.7%). In comparison with the rapidly growing mycobacteria (RGM) group, the slowly growing mycobacteria (SGM) group showed a lower resistance and a shorter hospital inpatient stay (t = 6.66, P < 0.001 and t = 2.40, P = 0.020, respectively). Conclusions: Mycobacterium chelonae/M. abscessus and M. intracellulare were the most frequently detected NTM pathogens in Northwest China. The differences in drug sensitivity and clinical characteristics were giant for different strains. Timely identification and accurate DST play important roles in NTM management. Keywords Prevalence Drug Resistance, Bacterial DNA microarray Polymerase Chain Reaction Nontuberculous MycobacteriaKeywords
This publication has 24 references indexed in Scilit:
- Pathogenesis and Risk Factors for Nontuberculous Mycobacterial Lung DiseaseClinics in Chest Medicine, 2015
- Epidemiology of Human Pulmonary Infection with Nontuberculous MycobacteriaClinics in Chest Medicine, 2014
- Increase in Nontuberculous Mycobacteria Isolated in Shanghai, China: Results from a Population-Based StudyPLOS ONE, 2014
- Prevalence and Drug Resistance of Nontuberculous Mycobacteria, Northern China, 2008–2011Emerging Infectious Diseases, 2014
- Diagnostic Accuracy of Quantitative PCR (Xpert MTB/RIF) for Tuberculous Meningitis in a High Burden Setting: A Prospective StudyPLoS Medicine, 2013
- Increasing Recovery of Nontuberculous Mycobacteria from Respiratory Specimens over a 10-Year Period in a Tertiary Referral Hospital in South KoreaTuberculosis and Respiratory Diseases, 2013
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery SystemsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Biochip System for Rapid and Accurate Identification of Mycobacterial Species from Isolates and SputumJournal of Clinical Microbiology, 2010
- EVALUATION OF THE BACTEC MGIT 960 TB SYSTEM FOR RECOVERY AND IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS COMPLEX IN A HIGH THROUGH PUT TERTIARY CARE CENTREIndian Journal of Medical Microbiology, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007